Skip to main content

LEVIN CAPITAL STRATEGIES, L.P.

Position in AURA — Aura Biosciences, Inc.

CIK 1354821 NEW YORK, NY

Position in AURA

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$6,297,966
+$654,023 QoQ
Shares Held
941,400
-9.1% QoQ
Ownership
0.911%
of shares outstanding
% of Portfolio
0.50%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2023
13 quarters on record
Voting authority Sole 0% Shared 92% None 8%

Common Shares in AURA Over Time

Shares Held

Position Value (USD)

Derivatives in AURA

reported options exposure · as of Sep 30, 2024
CallValue
$445,500
CallShares
50,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

LEVIN CAPITAL STRATEGIES, L.P. holds $12,744,736 across 8 Biotechnology names. AURA ranks #1 (49.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 AURA
Aura Biosciences, Inc.
This page
941,400 $6,297,966

All Filings in AURA

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $6,297,966 941,400
2025-12-31 $5,643,943 1,035,586
2025-09-30 $10,056,553 1,627,274
2025-06-30 $9,362,205 1,495,560
2025-03-31 $7,974,100 1,360,768
2024-12-31 $10,255,428 1,247,619
2024-09-30 $3,685,487 413,635
2024-09-30 $445,500 50,000
2024-06-30 $2,475,642 327,466
2024-03-31 $872,920 111,200
2023-12-31 $886,000 100,000
2023-09-30 $727,422 81,095
2023-06-30 $864,500 70,000
2023-03-31 $139,200 15,000